The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
SpineThera, Inc., a clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone ...
read more
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. and mAbxience, a Fresenius Kabi majority-owned group with...
read more
Ligand Pharmaceuticals announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of seasoned industry ...
read more
Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), announced a multi-year strategic partnership with Merck KGaA, ...
read more
dsm-firmenich, has announced a new strategic collaboration with Oz Medicann Group (OMG) Pharma – an Australian-based biotech innovator in the ...
read more
TME Pharma N.V. announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for NOX-A12 (olaptesed pegol), TME Pharma'...
read more
Charles River Laboratories International, Inc. announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing ...
read more
ARCA biopharma, Inc. and Oruka Therapeutics announced that they have entered into a definitive agreement to combine the companies in an all-stock ...
read more
The FDA approved Zevtera (ceftobiprole medocaril sodium for injection) for the treatment of adults with Staphylococcus aureus bloodstream infections (...
read more
Morris & Dickson announced it is the first U.S. distributor of Bavarian Nordic’s newly launched mpox vaccine, JYNNEOS®. As the only FDA-approved mpox ...
read more
Merck announced the initiation of a Phase 3 clinical trial evaluating MK-1084, an investigational oral selective KRAS G12C inhibitor, in combination ...
read more
Cardinal Health announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio, that will serve as a ...
read more
Otsuka Pharmaceutical, Co. Ltd. and Click Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared Rejoyn™ (developed...
read more
Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, announced the appointment of Karen Heim as Vice President and General Manager, Canada, ...
read more
AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the ...
read more